Does your integration playbook tackle tomorrow’s M&A challenges?
Explore EY insights on effectively attaining synergies through M&A integration.
Does your integration playbook tackle tomorrow’s M&A challenges?
Life sciences M&A optimism resulted in record deal announcements first quarter
Outcomes-based contracting in life sciences
2018 Global Corporate Divestment Study – Life Sciences
How robotics is reshaping the biopharma value chain
Life Sciences 4.0: Securing value through data-driven platforms
Choose your deal strategy wisely
2018 M&A Firepower Report: Life sciences deals and data
Looking beyond China to create a global IVD company
Life Sciences
The need for alignment to achieve health outcomes for all
As populations age and chronic diseases become commonplace, health care will take an ever larger share of GDP. Scientific progress, augmented intelligence and a more empowered patient are driving changes in the delivery of health care to a personalized experience that demands health outcomes as the core metric. This is causing a power shift among traditional stakeholder groups, with new entrants (often not driven by profit) disrupting incumbents.
Innovation, productivity and access to patients remain the industry’s biggest challenges. These trends challenge the capital strategy of every link in the life sciences value chain, from R&D and product supply to product launch and patient-centric operating models.
Our Global Life Sciences Sector brings together a worldwide network of 15,000 sector-focused professionals to anticipate trends, identify their implications and help our clients create competitive advantage. We can help you navigate your way forward and achieve sustainable success in the new health-outcomes-driven ecosystem.
The future of life sciences
EY brings together a global network of 15,000 industry professionals to anticipate trends and strengthen clients’ competitive advantage. Learn more about our life sciences services.
Contact us
Connect with us
Stay connected with us through social media, email alerts or webcasts.
The future of life sciences
EY brings together a global network of 15,000 industry professionals to anticipate trends and strengthen clients’ competitive advantage. Learn more about our life sciences services.
Navigating Brexit in life sciences
Life sciences companies weighing their options have a number of opportunities and risks to consider.